Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosastatin capsules in hemodialysis patients with erythropoietin resistance
ChiCTR1900026596Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Chengdu Medical College
- Start
- Oct 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of rosuvastatin in anaemia and end-stage kidney disease (ESKD) (2 arms), sponsored by The First Affiliated Hospital of Chengdu Medical College. Primary endpoints: Monthly changes in hemoglobin, Hemoglobin compliance rate and 1 more. Started Oct 2019; status: recruiting.
02
Drugs
rosuvastatin
03
Conditions
anaemiaend-stage kidney disease (ESKD)
Beyond the preview
Go deeper on ChiCTR1900026596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026596.